Ghana FDA's Safety Monitoring Department hosts the National Pharmacovigilance Centre and oversees medicinal-product safety monitoring.
Core official resources
- Safety Monitoring (Pharmacovigilance) — forms, safety-monitoring guidance, QPPV guidance and GVP inspection material.
- Safety Watch — electronic adverse-event reporting.
- Guidelines for Safety Monitoring — current adverse-reaction, medicinal-product safety, QPPV and inspection guidance.
Important national distinction
Ghana publishes explicit local guidance for Qualified Persons for Pharmacovigilance and GVP inspections. Company procedures should therefore be based on the Ghana FDA documents rather than assuming that regional or WHO guidance alone defines local expectations.